加州大学旧金山分校研究人员的一项新研究表明，难以每天服用艾滋病毒药物的患者可能会受益于长效注射治疗。这种方法还可以通过减少传染病患者的数量来帮助遏制艾滋病毒的传播。2021 年，联邦监管机构批准了首款长效抗逆转录病毒 (LA-ART) ...

Gilead Sciences, Inc. today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company's injectable HIV-1 capsid inhibitor, ...

Affordable housing is an issue for many older Americans. Members of the LGBTQ+ community are searching for solutions that ...

"Each kiss carries forward decades of hope and history, sparked by the belief that one day we’ll all be free.” ...

At a meeting that took place Feb. 28, Peter Marocco, the deputy administrator of the U.S. Agency for International ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...

The Labor Department will release the monthly jobs report card today, which is expected to show solid growth. But that's not ...

In his Tuesday address to Congress, President Trump listed U.S.-funded programs that he considers an "appalling waste" — ...

The U.S. recently backed out of the United Nation's HIV/AIDS program and froze billions in foreign HIV-prevention efforts.

The thrift store, which uses donations to support HIV/AIDS care and prevention, has now given away more than $5 million in ...

Scientific discoveries are necessary to eliminate epidemic diseases. But addressing socioeconomic factors is just as ...